Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00093275 · ClinicalTrials.gov registry record · Phase 2
HP184 in Chronic Spinal Cord Injury Subjects
A Phase 2 study, sponsored by Sanofi.
- Completed
- Registry status
- Phase 2
- Development phase
- 262
- Enrollment target
NCT00093275 is a Phase 2 study that has completed, run by Sanofi. The registered enrollment target is 262 participants.
The verdict
NCT00093275, a Phase 2 study, has completed, sponsored by Sanofi.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 262 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether HP184 is effective in the treatment of chronic spinal cord injury (CSCI).
Interventions
- DRUG HP184
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 262 participants |
| Start Date | 2004-10 |
| Est. Completion | 2005-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00093275
The ClinicalTrials.gov registry entry for NCT00093275 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 262 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi, which has 713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HP184 is the first listed.
NCT00093275 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00093275 about?
NCT00093275 is a clinical study titled "HP184 in Chronic Spinal Cord Injury Subjects". The purpose of this study is to determine whether HP184 is effective in the treatment of chronic spinal cord injury (CSCI).
What is the current status of trial NCT00093275?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 262 participants. The study started on 2004-10. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00093275?
The interventions under investigation include: HP184 (DRUG).
Who is sponsoring clinical trial NCT00093275?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.